Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use EVEROLIMUS TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for EVEROLIMUS TABLETS FOR ORAL SUSPENSION. EVEROLIMUS tablets for oral suspension Initial U.S. Approval: 2009
Medication labelWhy this: Advisory · dailymed-prescription
Everolimus tablets for oral suspension are indicated in adult and pediatric patients aged 1 year and older with TSC for the treatment of SEGA that requires therapeutic intervention but cannot be curatively resected. Everolimus tablets for oral suspension is indicated for the adjunctive treatment of adult and pediatric patients aged 2 years and older with TSC-associated partial-onset seizures.
- generic_name
- everolimus
- product_names
- Everolimus
- ndc
- 70377-090, 70377-091, 70377-092, 70377-090-11, 70377-090-23, 70377-091-11, 70377-091-23, 70377-092-11, 70377-092-23
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en